Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gerard

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Cancer Immunology, Immunotherapy : CII|May 8, 2023
Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patientsBerna C Özdemir, Cristina Espinosa da Silva, Dimitri Arangalage, et al.
Journal of Neurosurgery|February 21, 2003
Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusionAlejandro A Rabinstein, Mark A Pichelmann, Jonathan A Friedman, et al.
Cancer Immunology, Immunotherapy : CII|April 5, 2023
Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patientsBerna C Özdemir, Cristina Espinosa da Silva, Dimitri Arangalage, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2021
Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete responseFlorentia Dimitriou, Anne Zaremba, Clara Allayous, et al.
European Journal of Internal Medicine|October 22, 2024
Systolic blood pressure, a predictor of mortality and life expectancy following heart failure hospitalization, 2010-2023Mohammed Yousufuddin, Zeliang Ma, Ebrahim Barkoudah, et al.
Frontiers in Oncology|December 26, 2022
A differential process mining analysis of COVID-19 management for cancer patientsMichel A Cuendet, Roberto Gatta, Alexandre Wicky, et al.
PNAS Nexus|August 24, 2023
Anthropogenic uranium signatures in turtles, tortoises, and sea turtles from nuclear sitesCyler Conrad, Jeremy Inglis, Allison Wende, et al.
Nature Cancer|February 5, 2022
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanomaLisa Haas, Anais Elewaut, Camille L Gerard, et al.
European Journal of Cancer (Oxford, England : 1990)|December 8, 2024
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumorsFlorentia Dimitriou, Marlana M Orloff, Erica C Koch Hein, et al.
The Lancet. Oncology|August 2, 2021
Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' replyInes Pires da Silva, Tasnia Ahmed, Irene L M Reijers, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Cancer Immunology, Immunotherapy : CII|May 8, 2023
Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patientsBerna C Özdemir, Cristina Espinosa da Silva, Dimitri Arangalage, et al.
Journal of Neurosurgery|February 21, 2003
Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusionAlejandro A Rabinstein, Mark A Pichelmann, Jonathan A Friedman, et al.
Cancer Immunology, Immunotherapy : CII|April 5, 2023
Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patientsBerna C Özdemir, Cristina Espinosa da Silva, Dimitri Arangalage, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2021
Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete responseFlorentia Dimitriou, Anne Zaremba, Clara Allayous, et al.
European Journal of Internal Medicine|October 22, 2024
Systolic blood pressure, a predictor of mortality and life expectancy following heart failure hospitalization, 2010-2023Mohammed Yousufuddin, Zeliang Ma, Ebrahim Barkoudah, et al.
Frontiers in Oncology|December 26, 2022
A differential process mining analysis of COVID-19 management for cancer patientsMichel A Cuendet, Roberto Gatta, Alexandre Wicky, et al.
PNAS Nexus|August 24, 2023
Anthropogenic uranium signatures in turtles, tortoises, and sea turtles from nuclear sitesCyler Conrad, Jeremy Inglis, Allison Wende, et al.
Nature Cancer|February 5, 2022
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanomaLisa Haas, Anais Elewaut, Camille L Gerard, et al.
European Journal of Cancer (Oxford, England : 1990)|December 8, 2024
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumorsFlorentia Dimitriou, Marlana M Orloff, Erica C Koch Hein, et al.
The Lancet. Oncology|August 2, 2021
Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' replyInes Pires da Silva, Tasnia Ahmed, Irene L M Reijers, et al.
Pageof 13